Black Diamond Financial, LLC Concert Pharmaceuticals, Inc. Transaction History

Black Diamond Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$4.27 - $7.2 $8,540 - $14,400	2,000 Added 2.9%	71,000 $476,000
Q2 2022 Jul 27, 2022	BUY	$2.8 - $6.36 $64,399 - $146,280	23,000 Added 50.0%	69,000 $290,000
Q3 2021 Nov 02, 2021	BUY	$3.17 - $4.15 $36,455 - $47,725	11,500 Added 33.33%	46,000 $150,000
Q2 2021 Jul 27, 2021	BUY	$3.77 - $5.24 $130,065 - $180,780	34,500 New	34,500 $146,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Black Diamond Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Black Diamond Financial, LLC with notifications on news.